Drug
FOXY-5 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How studies write it
Studies that test it under each name
Name
- Foxy-5
- 3
Studies by the year they started
3 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
WntResearch AB (3)
Studies
Open first, then newest update. How each study uses FOXY-5 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon CancerStatus unknownPhase 2WntResearch ABNCT03883802Written as Foxy-5
- Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer PatientsCompletedPhase 1WntResearch ABNCT02655952Written as Foxy-5
- Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate CancerCompletedPhase 1WntResearch ABNCT02020291Written as Foxy-5
Codes
What other systems call FOXY-5 · ClinicalTrials.gg INT016211
- UNII (FDA) CBZ9UL0ARBFOXY-5Confirmed FDA, Wikidata
- Wikidata Q27216112foxy-5Confirmed FDA, Wikidata
- NCI Thesaurus C113435Wnt-5a Mimic Hexapeptide Foxy-5One source FDA
- DrugBank DB13034One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | CBZ9UL0ARB | FOXY-5 | Confirmed FDA, Wikidata |
| Wikidata | Q27216112 | foxy-5 | Confirmed FDA, Wikidata |
| NCI Thesaurus | C113435 | Wnt-5a Mimic Hexapeptide Foxy-5 | One source FDA |
| DrugBank | DB13034 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.